Jiayan Wu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 20
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 6
- Co-authors
- Huayu Tian (22 shared papers)Jie Chen (18 shared papers)Xuesi Chen (13 shared papers)Yuanji Feng (14 shared papers)Kanyi Pu (8 shared papers)Caina Xu (6 shared papers)Zhaopei Guo (8 shared papers)Lin Lin (7 shared papers)
- Journals
- Advanced Materials (4 papers)Biomaterials Science (4 papers)Nano Letters (3 papers)Nano Today (3 papers)Journal of the American Chemical Society (3 papers)
- Partner nations
- ChinaSingaporeNetherlands
In The Last Decade
Jiayan Wu
33 papers receiving 1.3k citations
Jiayan Wu's Hit Papers
Peers
Comparison fields: 5 of 90
- Biomaterials 300
- Biomedical Engineering 727
- Immunology 306
- Molecular Biology 570
- Pharmaceutical Science 49
Countries citing papers authored by Jiayan Wu
This map shows the geographic impact of Jiayan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Wu more than expected).
Fields of papers citing papers by Jiayan Wu
This network shows the impact of papers produced by Jiayan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Wu. The network helps show where Jiayan Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiayan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biomineralized Two‐Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy Hit paper breakdown → | 2022 | 169 |
| 2 | 2018 | 126 | |
| 3 | 2020 | 109 | |
| 4 | 2021 | 94 | |
| 5 | 2018 | 93 | |
| 6 | 2021 | 70 | |
| 7 | 2018 | 69 | |
| 8 | 2023 | 66 | |
| 9 | 2021 | 55 | |
| 10 | 2024 | 45 | |
| 11 | 2024 | 44 | |
| 12 | 2019 | 43 | |
| 13 | 2024 | 37 | |
| 14 | 2021 | 37 | |
| 15 | 2019 | 36 | |
| 16 | 2022 | 31 | |
| 17 | Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy Hit paper breakdown → | 2025 | 27 |
| 18 | 2024 | 27 | |
| 19 | 2019 | 24 | |
| 20 | 2019 | 22 |
About Jiayan Wu
Jiayan Wu is a scholar working on Biomedical Engineering, Molecular Biology, Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), RNA Interference and Gene Delivery (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Virus-based gene therapy research (4 papers) and Photodynamic Therapy Research Studies (3 papers). The work is most often cited by research in Biomaterials (300 citations), Biomedical Engineering (727 citations), Immunology (306 citations), Molecular Biology (570 citations) and Pharmaceutical Science (49 citations). Jiayan Wu has collaborated with scholars based in China, Singapore and Netherlands. Frequent co-authors include Huayu Tian, Jie Chen, Xuesi Chen, Yuanji Feng, Kanyi Pu, Caina Xu, Zhaopei Guo, Lin Lin, Lin Lın and Huapan Fang. Their work appears in journals such as Advanced Materials, Biomaterials Science, Nano Letters, Nano Today and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.